Auriga Downgrades ISTA Pharmaceuticals (ISTA) to Hold
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $9.09 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Auriga downgraded ISTA Pharmaceuticals (NASDAQ: ISTA) from Buy to Hold, price target raised from $8 to $9.
For an analyst ratings summary and ratings history on ISTA Pharmaceuticals click here. For more ratings news on ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $8.22 yesterday.
For an analyst ratings summary and ratings history on ISTA Pharmaceuticals click here. For more ratings news on ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $8.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- Stephens Downgrades Amerant Bancorp Inc (AMTB) to Equal Weight
- CFRA Downgrades 3M (MMM) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
